Literature DB >> 30351265

A mutation in anti-sigma factor MAB_3542c may be responsible for tigecycline resistance in Mycobacterium abscessus.

Hien Fuh Ng1, Joon Liang Tan2, Thaw Zin1, Sook Fan Yap1, Yun Fong Ngeow1.   

Abstract

In this study, we characterized 7C, a spontaneous mutant selected from tigecycline-susceptible Mycobacterium abscessus ATCC 19977. Whole-genome sequencing (WGS) was used to identify possible resistance determinants in this mutant. Compared to the wild-type, 7C demonstrated resistance to tigecycline as well as cross-resistance to imipenem, and had a slightly retarded growth rate. WGS and subsequent biological verifications showed that these phenotypes were caused by a point mutation in MAB_3542c, which encodes an RshA-like protein. In Mycobacterium tuberculosis, RshA is an anti-sigma factor that negatively regulates the heat/oxidative stress response mechanisms. The MAB_3542c mutation may represent a novel determinant of tigecycline resistance. We hypothesize that this mutation may dysregulate the stress-response pathways which have been shown to be linked to antibiotic resistance in previous studies.

Entities:  

Keywords:  MAB_3542c; Mycobacterium abscessus; RshA; anti-sigma factor; tigecycline resistance

Mesh:

Substances:

Year:  2018        PMID: 30351265     DOI: 10.1099/jmm.0.000857

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  2 in total

Review 1.  Genetic Determinants of Tigecycline Resistance in Mycobacteroides abscessus.

Authors:  Hien Fuh Ng; Yun Fong Ngeow
Journal:  Antibiotics (Basel)       Date:  2022-04-25

2.  RNA Sequencing Elucidates Drug-Specific Mechanisms of Antibiotic Tolerance and Resistance in Mycobacterium abscessus.

Authors:  Jodie A Schildkraut; Jordy P M Coolen; Sophie Burbaud; Jasper J N Sangen; Michael P Kwint; R Andres Floto; Huub J M Op den Camp; Lindsey H M Te Brake; Heiman F L Wertheim; Kornelia Neveling; Wouter Hoefsloot; Jakko van Ingen
Journal:  Antimicrob Agents Chemother       Date:  2021-10-11       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.